Category Archives: OxySure Systems Inc. OXYS

OxySure Systems, Inc. (OXYS) Gaining Global Marketplace Traction

December 23, 2013

OxySure Systems is a Texas-based medical technology company that designs, manufactures, and distributes specialty respiratory and medical solutions. The company is the creator of a groundbreaking medical technology that allows oxygen to be delivered on demand, via the instantaneous creation of medically pure oxygen from two dry, inert powders. Since the product is revolutionary, is easy to operate, does not require specialized care or maintenance, and has potential to become a mainstream medical device, it is already gaining traction in the global medical device marketplace.

OxySure Systems’ launch product, the OxySure Model 615, uses this technology to enable parents, passersby, or even victims to administer oxygen when it is needed in a medical emergency. The machine model is already an FDA-cleared model that has been installed and used in multiple facilities across the United States. A user only has to turn a knob, and the OxySure Model 615 is ready for instant use. The product is already gaining the attention of many inside and outside the medical technology industry, having received numerous accolades such as the Tech Titans Innovation Award in 2008 and MedVentures Award in 2011. It does not require a prescription for over-the-counter sale, either.

The global market potential for the OxySure Model 615 has been put at over 500 million units, with locations such as school campuses, manufacturing facilities, churches, and restaurants being mentioned as prospective places for product placement and installation. OxySure Systems has also been investigating the viability of the OxySure Model 615 being placed in more unique locations such as recreational vehicles. With the strong potential to become used as a mainstream medical device, the machine model may become as standard a medical unit in these locations as the fire extinguisher or the automated external defibrillator. End markets for the OxySure Model 615 in the United States alone could edge into the installment of over 100 million machine model units.

OxySure Systems has created a recurring revenue model with this machine model, as it possesses reusable hosing and a replaceable cartridge that must be replaced after each use or the end of a two-year shelf life. As more units are introduced into more global locations, this can turn into a stronger recurring revenues model. Additionally, the company’s oxygen creation technology gives it the capacity for other vertical markets as well.

Currently, OxySure Systems is seeking to further its product’s global presence through the establishment and leveraging of key partnerships with global distributors and large original equipment manufacturers worldwide.

This month has been a busy one for OxySure Systems. It just finished exhibiting at the world’s largest medical device tradeshow, the Medica 2013 Trade Fair. Taking place over four days, the convention reportedly attracted around 130,000 attendees a day. OxySure Systems subsequently received many inquiries about and distributor interest in its oxygen-providing technology. The company also solidified partnership deals with distributors in Hong Kong, Macau, and Chile. There is room for further distributive deals from the conference as well.

During Q3 2013, the company reported sales had jumped 428 percent. An early-December Wall Street Cheat Sheet article noted OxySure Systems as being an emerging attractive investment opportunity in the evolving marketplace of healthcare. Since it is an over-the-counter product, the OxySure Model 615 likely will not feature the medical device tax imposed by the Affordable Care Act.

With the OxySure Model 615 sporting groundbreaking oxygen-creating technology as its foundation and having potential to emerge as a mainstream medical device, OxySure Systems is on the road to gaining strong global marketplace growth.

For more information, visit:

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Extends Market Reach in Hong Kong, Macau with New Distribution Partner

December 18, 2013

OxySure Systems, a medical technology company that has pioneered a solution to produce medically pure oxygen from inert powders, reports that Pacific Medical Systems Ltd. has agreed to be the exclusive distributor of OxySure products in Hong Kong and Macau.

Pacific Medical Systems is a distributor of automated external defibrillators (AEDs) in Hong Kong, a region without time-consuming registration requirements. The new three-year agreement with OxySure requires minimal sales order commitment of 11,800 units of the OxySure Model 615 and OxySure Replacement Cartridges through the course of the agreement.

“We are pleased to add Pacific Medical Systems to our growing list of global distribution partners,” Julian Ross, CEO of OxySure, stated in the news release. “Pacific Medical Systems has been a trailblazer in the sale of AEDs in Hong Kong and we look forward to working with Jules Flach and his team to establish a strong presence in Hong Kong and Macau for OxySure. What is unique about Hong Kong in particular is that there is currently no mandatory medical device registration or approval process which means we can get down to business right away.”

Based in North Point, Hong Kong, Pacific Medical Systems specializes in the marketing, sales, and after sales support of innovative medical products in the Asia Pacific region. The company is comprised of professionals with experience from multinational companies in the medical field.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Secures Distribution Partner in South America

December 11, 2013

OxySure Systems, a medical technology company that has pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders, has signed a distribution agreement with Tecnología Contra Incendios Python E.I.R.L. (“Python”) to represent OxySure in its market penetration in Chile, South America.

This is the first distribution agreement stemming from OxySure’s exhibition at Medica 2013, the international medical tradeshow in Dusseldorf, Germany, in November 2013.

Santiago, Chile-based Python sells safety equipment and supplies to mining and manufacturing companies, service organizations, government departments, some health centers, and fire and traffic departments. The company’s product lines include first aid, rescue and emergency products, safety cans and cabinets, firefighting products, spill containment products, and traffic managements products.

“We are pleased to add Python to our fast growing list of international distribution partners,” Julian Ross, CEO of OxySure stated in the news release. “Chile is considered one of South America’s most stable and prosperous nations, with a population of approximately 17.4 million people. Python has a good understanding of the first aid and safety market segments in Chile.”

OxySure notes that the distribution agreement is non-exclusive and contains minimum annual order quantity provisions.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Establishes Key Relationships at Medica 2013 Trade Fair

December 5, 2013

OxySure® Systems announced earlier today an update from the Medica 2013 Trade Fair in Dusseldorf, Germany, the largest medical device trade show in world, with approximately 130,000 attendees per day over the four day trade fair. According to the press release issued, OxySure has experienced a high volume of inquiries regarding its proprietary respiratory solutions. In fact, several different countries have begun negotiations on distribution agreements to expand the OxySure brand and products.

“We are extremely pleased with the outcome of our presence at Medica 2013,” stated Julian Ross, CEO of OxySure Systems. “There was a level of excitement from all the visitors to our booth and we have already begun negotiations with over a dozen countries regarding our groundbreaking oxygen from powder solutions. We feel confident that this will enable OxySure to continue expanding its presence on a truly global scale.”

OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the oxygen-generating technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Guided by Innovators with Decades of Experience

November 27, 2013

OxySure Systems, a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, has developed a safe and easy-to-use solution to produce medically pure (USP) oxygen from inert powders.

The company owns numerous issued patents and patents pending on this technology, which is designed to make the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.

OxySure’s efforts are guided by CEO Julian T. Ross, who is also the OxySure founder and technology developer (holds nine patents).

With more than 25 years of experience in technology, manufacturing and finance, Ross has managed development of production capabilities, partnerships and alliances; managed the development of sales, distribution and licensing partnerships; raised in excess of $14 million in debt and equity to fund operations; and took OxySure public in 2011 through an S-1 registration with the Securities and Exchange Commission.

Ross is backed by a highly experienced team of directors and an equally as knowledgeable advisory board. Collectively, the team has experience in healthcare, management, business development, mergers & acquisitions, operations, private practice medicine and more.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

Growing Customer Base, Distribution Deal Fuel Continued Top-Line Growth for OxySure Systems, Inc. (OXYS), Says Zacks Analyst

November 20, 2013

OxySure Systems, a medical technology company focused on the design, manufacture and distribution of specialty respiratory and medical solutions, and developer of a proprietary process to produce medically pure (USP) oxygen from inert powders, was recently the topic of a Seeking Alpha article discussing the company’s trek toward profitability.

To read the article in its entirety visit

OxySure November 14 reported its third-quarter financial results, posting revenues of $546,000, a stunning increase of 428 percent compared to revenues in the comparable quarter of last year and an increase of 15 percent from the second quarter of 2013.

Zacks analyst Jason Napodano, CFA, in his article notes that OXYS revenues topped expectations by $100,000, and that the firm expects the company to enter into the fourth quarter and 2014 with continued top-line growth.

In explaining supporting factors for this forecast, Napodano highlights OXYS’ 2013 partnerships and distribution agreements:

• March 2013 – deal with Aero Healthcare includes purchase order of at least 4,500 units of Model 615
• May 2013 – distributing deal with Medizon B.V. includes minimum purchase order of 2,250 units of Model 615
• May 2013 – approval to market the Model 615 and related accessories in Israel
• June 2013 – distribution agreement with Aventric Technologies

Napodano also takes into consideration several other company achievements, as well as in further detail discusses OXYS’ financial performance and growing customer base.

In conclusion, he writes, “It is likely, given the current trajectory of the top-line, that OxySure can achieve cash flow positive operations by the end of 2014. Therefore, we think new investors that have previously shunned the story due to the weak cash position and drip financings may start to be attracted to the story starting in 2014. We built a 10-year discounted cash flow model that pegs fair-valuation between $1.50 and $2.00 per share (assumption to be narrowed once the company secures long-term financing).”

For more information on OXYS, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Cuts Q3 Loss, Achieves Third Consecutive Quarter of Growth as Sales Increase 428%

November 14, 2013

OxySure Systems, a medical technology company focused on the design, manufacture, and distribution of specialty respiratory and medical solutions, today in its third-quarter financial and operating results posted its third consecutive quarter of triple-digit revenue growth and a narrowed net loss.

“We had an excellent building quarter and we are pleased to have sustained our positive momentum for the year so far,” Julian T. Ross, CEO of OxySure stated in the news release. “Our results for the third quarter reflect our continued success at executing on strategic initiatives aimed at generating superior top-line growth while staying focused on controlling our expenses. We plan to continue our strategy of building awareness for our new and innovative lifesaving products, while investing in branding, distribution, R&D and sales. We are excited about some of the initiatives we are currently working on.”

Total revenues for the quarter increased 428 percent to $545,820, as compared to revenues of $103,327 in the third quarter of last year.

Gross profit increased approximately 722 percent to $434,710 from $52,855 a year ago.

The company cut its net loss by approximately 38.3 percent to $82,613, or $0.00 per share, from a net loss of $133,779, or a loss of $0.01 per share, reported in the year ago period.

Selling, general, and administrative expenses increased to $478,518 from $206,810 for the comparable quarter of 2012, reflecting ramped up sales and marketing expenses as the company worked to expand its sales and branding efforts. Research and development expense during the third quarter of 2013 was $134,357 as compared to $579 for the third quarter of last year.

OxySure said it continues to execute on its core growth strategy to grow its sales and distribution both domestically and abroad, and recapped key milestones of 2013, including new distribution agreements and product launch.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Spotlighted Amid Oxygen Biotherapeutics, Inc. (OXBT) Activity

November 8, 2013

Shares of biotech company Oxygen Biotherapeutics have recorded a week-long trading frenzy, Wednesday surging to a six-month high of $11.21, today up 12% at $6.70 as of 11 a.m. ET, and notching a gain of 175% over the past week on huge volumes.

Oxygen Biotherapeutics develops medical products designed to deliver oxygen to tissues throughout the body, as well as similar products for personal care, topical wound healing and more. The trading activity comes after the company said it signed a licensing agreement, expanding its product lines.

As a recent article on Marketwatch points out, coverage of the company’s products and operations have shed light on other players in the oxygen business, including OxySure Systems, Inc., a medical technology company focused on the design, manufacture and distribution of specialty medical and respiratory solutions.

To read the full article visit:

While OxySure shares movement doesn’t parallel the gains of Oxygen Biotherapeutics, shares jumped $0.05 following the release of the article, which details OySure system’s FDA-approved power-to-oxygen process as well as the company’s potential investment opportunity.

OxySure’s proprietary process produces medical-pure oxygen from dry, inert powders for use in emergency and short-duration situations. The device is simple enough that it can be used by any layperson.

As the article states, “With the potential to become the equivalent of the next AED in the medium term and the equivalent of a fire extinguisher in the long term, OxySure’s Model 615, already FDA approved for over the counter sale (no prescription required), has a significantly larger end market than Oxygen Biotherapeutics PFC-based drugs. The installed base for AEDs exceeds two million units, while fire extinguishers exceed 100 million units in the U.S. alone. Capturing just a fraction of this market with its unique emergency oxygen solution could represent a multi-billion dollar opportunity that could unlock significant long-term shareholder value. It is more likely than not that OxySure will capture a significant share of the market because it is the only player that has this product and technology. OxySure pioneered this technology, and owns numerous patents and patents pending around it, and has first mover advantage.”

The article also recaps the company’s financial position, noting that second-quarter revenues surged a whopping 650% to $476,071; SG&A expenses down 18% to $194,803; interest expenses 60% at $23,254; and a net loss narrowed by 11.8%. Also notable, Sterling Investments analysts issued a Buy rating on the stock with a $1.90 per share 12-month price target.

In conclusion, the author writes, “The positive financial momentum has been followed by a number of promising recent developments. In July, the company launched an AED/OxySure double wall cabinet to house its product next to the ubiquitous AED. In October, the firm announced a partnership that lets dozens of banks compete for leases on OxySure’s products with a simple 2-minute application. Creating the ability for customers to lease OxySure’s products significantly expands the market. Combined, these two developments could significant expand its market moving forward.”

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Avoids Complexities of Traditional Systems for Dental or Medical Office Emergencies

October 30, 2013

A recent article promoting the importance of emergency oxygen for dental offices broke down some of the things involved in adequately providing for such situations using traditional oxygen tanks, information applicable to similar environments.

First of all it emphasized the need of having a separate portable oxygen system that is dedicated to dealing with emergencies, indicating that a standard centralized system that depends on H-size oxygen cylinders might not have the necessary reach for a patient in a waiting room or other area. Moreover, such centralized systems might not offer the positive pressure required for proper resuscitation, and that a portable cylinder, including a bag-valve-mask resuscitator or demand valve, is better. It also spoke about mobile oxygen carts to provide mobility for larger oxygen tanks. Not mentioned, but equally important, are the steps required to safely maintain traditional pressurized oxygen equipment and ensure that staff is properly trained in its use and upkeep.

OxySure has what it is convinced is a better answer, not only for medical offices but for virtually any public or private location that might face an oxygen emergency, such as someone having an asthma or heart attack. The OxySure approach avoids pressurized tanks, and all of the safety and maintenance issues involved with them. The company instead uses a patented technology that delivers medically pure oxygen instantly, on demand, from two dry and inert powders. Their system is so simple that any layperson is able to use it quickly and safely. There’s no risk of tanks ever overheating and exploding, and there’s virtually no maintenance, and no hydrostatic testing, batteries, or other complexities. It’s always ready to use, easy to move, and a breeze to operate. And the system’s small size and lightweight also makes it easy to store, meaning that multiple units can be kept on site to fit any extended use or other emergency scenarios.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Exhibits Profit Potential with Leading-edge Oxygen Technology

October 23, 2013

Any savvy investor can speak of the wisdom of looking at investment opportunities that breach new or virtually untapped markets. Companies that design and commercialize products or services that exhibit promise for defining their industry space or steering their industry in a new direction can often be cases for strong profit potential. Frisco, Texas-based OxySure Systems says it is doing just that, as it has created a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders and enables this oxygen to be delivered on demand anywhere.

OxySure Systems’ launch product, the OxySure Model 615, harnesses this technology to enable a parent, bystander, or victim himself or herself to administer lifesaving oxygen in the event of a medical emergency. Its operation is simple: just a turn of its knob, and the device is ready to go. The company notes that the OxySure Model 615 is an emerging technology that will be a strong asset in helping its users in life-threatening circumstances as they are waiting for first responders to arrive.

The model’s breakthrough technology, combined with its ability to be used by anyone without any special training and its lacking any need for special maintenance, position it for strong market potential as OxySure Systems moves to make it a standard installed medical device in multiple private and public settings. To illustrate its market potential: OxySure targets enormous end markets that are at least as large as the install base for AEDs, which exceeds two million units, and potentially as large as the fire extinguisher base, which exceeds 100 million units in the U.S. (500+ million units globally). In concrete terms, OxySure Systems is taking efforts to initially target the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, and 950,000 restaurants in the U.S. as product installation sites. The product also features a reusable housing and a replaceable cartridge, which must be replaced after each use or upon expiry of a two-year shelf life. Over time, this could result in recurring revenues and greater earnings predictability.

The OxySure Model 615 has been cleared by the U.S. Food and Drug Administration for over-the-counter sale, meaning that no prescription is needed to obtain it. It can be used for immediate on-the-scene oxygen supplication for well over 20 unique general or civic emergencies, as well as numerous homeland security applications. There are no hidden dangers in its operation, either—the powders used for oxygen creation are dry and inert until the product’s knob is turned, instantly creating medical grade oxygen. Thus no explosive, fire, environmental, or toxicity hazards are associated with the device’s use. Along with no requirements for specialized device training or product maintenance, the OxySure Model 615 also does not require any specialized testing or licenses and permits for operation.

The OxySure Model 615’s strong market viability, along with its lack of requirements for usage, may make it a solid opportunity for investors to consider. For socially conscious investors who are concerned about the effects of their investments, the OxySure Model 615 represents the best of both worlds: an attractive investment opportunity that exhibits strong market potential while truly making a difference.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Opens Larger Market Opportunity with Financing Service

October 15, 2013

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, reported the launch of OxySure Commercial Finance(SM), a service that enables easy and convenient lease of OxySure’s suite of medical devices and products, including the OxySure Model 615, Automated External Defibrillators (AEDs), and other medical equipment, supplies and accessories.

Powered by LeaseQ, OxySure’s new service allows customers to do comparison shopping for lease quotes from dozens of third party lenders with one simple online form that takes only two minutes to complete. The system can pre-qualify customers instantly and display the top results, allowing customers to select from multiple, pre-qualified offers. The system also provides customers the flexibility to select lenders of choice and payment plan characteristics such as monthly payment, finance term and terminal value.

Julian T. Ross, CEO of OxySure, stated, “We are excited about the OxySure Commercial Finance(SM) program because the program makes it easy to differentiate OxySure sales with financing options wherever OxySure products are sold. By offering our customers the opportunity of an attractive monthly cost via third party financing, OxySure products and solutions become significantly more affordable. The program can also facilitate or fast track the purchasing process and can typically provide tax advantages to corporate buyers.”

More information can be found by visiting the following link:

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Demonstrates Growth through Positive Second Quarter Results

September 30, 2013

OxySure Systems is showing sure signs of progress and momentum, as demonstrated by its performance over the past few quarters and data released this week on this year’s second quarter earnings.

On August 13, 2013, the company reported its second quarter financial results for the period ending on June 30. Total revenues were reported at $476,000, a 657% increase over the same period in 2012 and 98% sequentially from the first quarter of this year. Revenues consisted of $364,000 in products sales and $113,000 in revenues under licensing and service agreements.

Operating expenses for the second quarter totaled $664,000, consisting of $152,000 in cost of goods sold, $133,000 in sales and marketing, $195,000 in general and administrative, and $183,000 in research and development. The company’s gross margin hit 68% in the second quarter, up from 60% in the same period of last year.

The company’s operating expenses continue to remain under control; net loss totaled $193,000, a $25,000 improvement from the second quarter 2012. OxySure exited the second quarter with $96,000 in cash. Operating and investing cash burn totaled $293,000, however, the company saw a number of warrants exercised that provided approximately $294,000 in cash. The company continues to fund operations through warrant exercising and small equity “drip” financings.

Over the past year, the total number of derivative securities outstanding was reduced by approximately 2.038 million. As of June 30, OxySure had $288,000 in inventory on the books. Total assets increased to $1.37 million as of the same time, up from $1.21 million at the end of December 2012. Although still not yet profitable, OxySure is clearly moving in the right direction.

Analysts believe that OxySure’s top-line growth is being driven by a combination of new customer wins, continued business with existing customers, a new and growing military business, and signing new distribution partners in the U.S. and internationally.

One product in particular, the Model 615 Emergency Oxygen System, which is designed to deliver supplemental oxygen in medical emergencies, is a potential breakthrough product that could help the company achieve real gains over the next few years. This, and the company’s significant growth, leads many to believe that the company will generate a positive cash flow by 2016 and could generate over $10 million in operating cash flow by 2018.

The positive developments seen in the first half of this year are expected to continue as 2013 wraps up, as OxySure has been very active in signing new partnerships and distribution agreements. In March, the company signed a deal with Aero Healthcare for a minimum purchase order of 4,500 units of the Model 615. In May, OxySure signed a deal with Medizon B.V. Medizon for distribution of Automated External Defibrillators (AEDs) in the Netherlands, Belgium, and Luxembourg, and will now distribute the Model 615 as well. The deal comes with a minimum purchase order of 2,250 units.

A month later, in June, OxySure signed a non-exclusive distribution agreement with Aventric Technologies to sell the company’s full portfolio of products. Aventric Technologies has a strong presence in the K-12 education market, and also sells imaging and medical equipment, including AEDs, to hospitals, clinics and other alternative point-of-care facilities.

With an expanding product line and an increasing number of distribution agreements, the positive momentum clearly evident in the first half of the year is expected to carry over to the third and fourth quarter.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) to Exhibit Innovative Oxygen Technology at the Annual National Safety Council

September 26, 2013

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, will be an exhibitor at the National Safety Council’s (NSC) 2013 Congress & Exposition, the world’s largest annual event for safety, health, and environmental professionals. The event is taking place in Chicago from September 30 – October 2, 2013.

NCS provides a way for OXYS to showcase its technology to Congress and expo attendees as members of the OXYS team will be discussing and providing demonstrations of its “oxygen from powder” technology and the company’s leading edge respiratory and medical safety solutions for lay rescuers.

OXYS’ exhibit will feature the OxySure Model 615 portable emergency oxygen device, “combo” solutions with various Automated External Defibrillators (AEDs), and other solutions which combine medical safety, ease of use, and value.

The company will also provide information on how its technology can help organizations achieve or enhance their employee safety and health preservation goals in a cost-effective manner.

OXYS’ products improve access to emergency oxygen that affects the survival, recovery, and safety of individuals for several areas of need, such as public and private places and settings where medical emergencies can occur; for individuals at risk for cardiac, respiratory, or general medical distress needing immediate help prior to emergency medical care arrival; and individuals requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other potentially hazardous settings.

OXYS manufactures its products in Frisco, Texas. The product has also been deployed in several other countries, including Brazil, Israel, Turkey, and South Africa.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Provides Progress Update on CE Marking

September 24, 2013

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, this morning gave investors a progress report on the CE Marking of its flagship product, the OxySure Model 615.

The company received notice earlier this month of an opinion rendered by the Medicines and Healthcare products Regulatory Authority (MHRA) in the United Kingdom related to the classification of the OxySure Model 615 as a medical device. An opinion of this nature by a competent authority is a key step in the CE Marking process.

“We are pleased with this opinion from MHRA,” commented Mark Gilmore, Managing Partner of Aero Healthcare, OxySure’s partner in the United Kingdom. Gilmore, who oversees the CE Marking process, added, “In addition, we have already substantially completed our technical file for the CE Marking process and we plan to move forward post haste with our notified body on the next steps of the CE Marking of OxySure.”

The CE marking will enable the free movement and sale of products within the European market. With the marking, OxySure’s approved products can be sold in approximately 31 countries in the European Economic Area (EEA), comprising the 28 Member States of the European Union and the European Free Trade Association (EFTA) countries of Iceland, Norway, and Liechtenstein. As of January 1, 2012, the population of the European Union was approximately 503.5 million people.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Kept with Buy Rating at Sterling Investment Services, PT Set at $1.90

September 17, 2013

Analysts at Sterling Investment Services today reiterated the Buy rating on medical technology company OxySure Systems. The firm set a 12-month price target of $1.90 on OXYS’ common stock.

This is the third recently issued Buy rating on OXYS with a price target in the range of $1.75 to $2.10.

OxySure focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered an FDA-approved solution to produce medically pure (USP) oxygen from inert powders for emergency and short duration use. The company owns several issued patents and patents pending on this technology, which makes the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems.

To see the Sterling report in its entirety, visit For more information on OxySure, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) CEO Highlights Life Saving “Oxygen from Powder” Technology during Interview with The Stock Radio

September 10, 2013

OxySure Systems, a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today, was recently featured in an interview produced by The Stock Radio. Julian T. Ross, Chairman of the Board and CEO, discussed OxySure’s proprietary technology, the wide-spread application of this technology to save lives, and the company’s aggressive growth strategy and recent achievements.

The interview is available at:

“This year we announced a very good milestone for us – a very exciting one…we’ve hit the 2,000 lives saved mark with this product.” Ross says in the interview. He also provides several specific examples of how the technology has saved lives by bridging the gap between the onset of a medical emergency and the arrival of first responders on the scene.

OxySure owns several issued patents and patents pending on its oxygen production technology and expects to penetrate a number of new markets in the near future.

For additional information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Offers Superior Source of Emergency Oxygen

September 6, 2013

When an industry changing idea comes along, it isn’t long before people start to recognize its importance and wonder why it wasn’t developed earlier. Such is the case with OxySure Systems, inventors of a revolutionary way to supply oxygen for use in emergency situations, an approach that is safer, simpler to maintain, more affordable, and easier to use than conventional oxygen tanks.

OxySure’s patented system is based upon two dry, inert, proprietary powders, which, when activated, produce medically pure oxygen. There are no compressed oxygen tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, no required training, and none of the hazards associated with traditional oxygen provision systems. For the first time in history a lay rescuer – a bystander or loved one – can safely administer medical oxygen during those first critical minutes after an emergency occurs, improving outcomes and saving lives.

A recent video out of Colorado Springs, reported on ABC 7 in Denver and other news stations, reveals the potential hazards associated with traditional oxygen canisters ( The video, which quickly went viral, shows emergency responders preparing to put out a car fire caused when one car was hit by another. Suddenly the car on fire explodes, shooting debris flying into the air, damaging two police cars and a fire truck. Fortunately nobody was injured, but the cause of the explosion was determined to be oxygen canisters that were being carried in the trunk of the car. Perhaps most telling was a comment about the video left by someone identifying themselves as a former nurse, expressing their concern about all the people now on portable oxygen that do not follow safety guidelines.

OyxSure emergency oxygen systems are safe and easy to use, and are currently found in schools in over 40 states in the U.S., and are now being adopted in many other countries.

For additional information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

Taglich Brothers Reiterates Buy Rating on OxySure Systems, Inc. (OXYS); Target Price $2.10 Per Share

August 27, 2013

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, was reiterated with a Speculative Buy rating from analysts at Taglich Brothers. Taglich Brothers set a 12-month price target of $2.10 on the stock.

In the research update, Taglich Brothers also raised its revenue estimates for OXYS in anticipation of higher sales partially attributable to the company’s military business. The research firm expects sales to rise from $2 million in 2013 to $4.9 million in 2015. By 2017, revenues are projected to increase to $18 million.

To see the 15-page report in its entirety, follow the link posted under additional resources at

Let us hear your thoughts: OxySure Systems Inc. Message Board

QualityStocks Features OxySure Systems, Inc. (OXYS) CEO in Exclusive Interview

August 20, 2013

Today before the opening bell, QualityStocks announced that a new audio interview with OxySure Systems, Inc. is available. The interview can be heard at

OXYS is a medical technology company that has pioneered a solution to produce medically pure oxygen from inert powders. The company’s flagship product, the OxySure Model 615, is both safe and easy-to-use for the layperson. Like an AED or fire extinguisher, Model 615 can be placed just about anywhere a medical emergency might occur to help improve medical outcomes and save lives by providing potentially life-saving oxygen in a medical emergency before the arrival of first responders.

In the interview, Julian Ross, Chairman, CEO of OXYS, detailed the company’s patented technology, its current applications, as well as future plans for widespread installation both in the U.S. and abroad.

“We’ve been able to accomplish a lot in 2013 so far, and we’re just halfway,” says Ross, describing the company’s achievements this year, including new domestic installations of Model 615 and recent worldwide contracts.

Ross also highlights second-quarter financial results, in which the company posted significantly higher sales and a narrowed quarterly loss. The company grew second-quarter sales by approximately 657% to $476,071, marking the company’s second consecutive quarter of triple-digit revenue growth.

“We’ve been excited about our results for the second quarter. We have focused — and this has been a big goal for us — to grow the top line. We’ve been able to do that and we’ve set a trend,” says Ross.

For more information, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Triples Revenue for Second Consecutive Quarter

August 13, 2013

Today before the opening bell, OxySure reported its financial and operating results for the second quarter ended June 30, 2013.

Second Quarter 2013 Highlights:

  • Total revenue increased by about 657% to $476,071
  • General and administrative expense down by about 18%      to $194,803
  • Interest expense down by about 60% to $23,254
  • Net loss declined by about 11.8%
  • Working capital deficit improved by about $1,926,481
  • Stockholder deficit improved by about $2,359,951
  • Gross profit increased 758%; gross margins up to      68% from 60%
  • Net loss per share for the quarter stayed flat at      $.01

“We sustained positive momentum in the second quarter, and we are pleased that our financial results continue to show rapidly improving fundamentals,” said Julian T. Ross, Chairman of the Board and Chief Executive Officer of OxySure. “Our growth in the second quarter represents another record as the benefits of prior and current research and development and marketing initiatives have begun to materialize. We are growing stronger, and we intend to continue to build on our positive momentum, while continuing to invest in branding, distribution, R&D and sales to drive our business plan forward.”

For the three months ended June 30, 2013, revenues increased to $476,071, representing an increase of approximately $413,180 or 657% as compared to $62,891 for the three months ended June 30, 2012. The increase was driven by a $344,731 or 1,906% increase in product sales in the United States and $112,500 in revenues from licensing and service agreements. The Company added a significant new distributor in the AED sector in the Netherlands, Belgium, and Luxembourg during the second quarter of 2013, further expanding its presence in the international “AED companion market.” Revenues from products for the military increased significantly as a result of a teaming agreement.

Gross profit was $323,599 for the three months ended June 30, 2013, an increase of $285,864 or 758% from $37,735 in the same period last year, primarily due to significantly higher product and service sales. Gross margin was 68%, up from 60%.

Selling, general and administrative expenses were $511,980 compared to $256,754 for three months 2012. The Company increased sales and marketing expenses from $18,134 to $133,730 as it expanded its sales and branding efforts. OxySure also recorded an increase in research and development expenses primarily attributable to an increase in research and development expense recognized in connection with products for military markets. These increases are partially offset by a decrease in other general and administrative expenses, which fell by 18% to $194,803 as compared to $237,445 for the prior period. The decrease in other general and administrative expense was primarily as a result of a decrease in depreciation and amortization expense, a decrease in employee stock option expense, and a decrease in professional fees.

Interest expense fell 60% to $23,254 for the second quarter of 2013 from $57,462 during the second quarter of 2012.

Net loss decreased to $192,609, or $0.008 per share, compared to $218,472 or $0.01 per share for the second quarter of 2012. The weighted average diluted shares outstanding were 23,167,439 and 19,807,432 for second quarters of 2013 and 2012, respectively.

The total number of derivative securities outstanding reduced by approximately 2,038,455 or 31% from June 30, 2012 to June 30, 2013.

Total assets increased to $1,366,524 at June 30, 2013 from 1,215,797 at December 31, 2012. The company continues to opportunistically evaluate various debt and equity options to finance its growth.

Business updates

OxySure continues to execute on its core growth strategy of:

  • Expand its sales and distribution footprint in the U.S. and internationally
  • Leverage distribution partnerships to enhance market penetration
  • Diversify product offerings through additions of complimentary or additive products/services
  • Promote market awareness and education through industry partnerships

Key milestones achieved so far in 2013 include:

  1. Signed a distribution agreement with Dutch conglomerate Medizon B.V. to distribute products in the      Netherlands, Belgium and Luxembourg
  1. Launched a new product, a double wall cabinet to house a combination AED/OxySure system
  1. Added new distributors in the United States to expand distribution footprint

Conference Call

OxySure’s CEO Julian Ross is hosting a conference call this morning to discuss the company’s growth strategy and recent developments.

Date: Tuesday, August 13, 2013
Time: 9:00 am ET
US Dial-In: 1 (866) 352-2112
International Dial-In: 1 (630) 691-2779
Conference ID: 7064 119

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Schedules Q2 2013 Financial Results Conference Call

August 9, 2013

Earlier today, OxySure Systems announced that it will be holding a conference call at 9:00 am ET on Tuesday, August 13, 2013, to discuss its financial results for the three months ended June 30, 2013. CEO Julian Ross will be hosting the call.

Those who wish to participate in the call should dial in using the information below.

Date: Tuesday, August 13, 2013
Time: 9:00 am ET
US Dial-In: 1 (866) 352-2112
International Dial-In: 1 (630) 691-2779
Audience Passcode: 7064 119

Those unable to attend can access a playback of the call on the investors section of the company’s website at

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure Systems, Inc. (OXYS) Engages DTG to Enhance Corporate Communications

August 6, 2013

Today before the opening bell, OxySure announced that it has enlisted the investor relations (IR) and social media relations (SMR) services of DreamTeamGroup (DTG). Leveraging a network of investor-oriented sites and full team of dedicated professionals, DTG broadens the influence of publicly traded companies and enhances their ability to attract growth capital as well as improve shareholder value.

“Leveraging numerous patents and patents pending, OxySure has demonstrated its ability and dedication to consistently create new products and opportunities, and build company value,” stated Sherri S. Franklin, Director of Marketing at DTG. “OxySure has positioned itself to capitalize on a wealth of market opportunities by fostering several partnerships with leading companies in the emergency medical, EMS, first aid, safety and MRO markets.”

Julian T. Ross, CEO of OxySure, commented, “We have pioneered our patent protected technology and are the first to market these products, a significant step in establishing our foothold in the industry. By engaging a reputable full-service investor relations firm we are prepared to further extend our global market reach and enhance social media communications. DTG is providing a much needed service in the small-cap markets.”

DreamTeamGroup (DTG) combines very different, but complementary marketing avenues into one dynamic approach. This interlocking marketing convergence tackles many obstacles in the marketing process by engaging many different types of individuals with compelling content. By providing unique offerings, DTG has become a valuable advertising outlet garnering a top placement in traffic and unique hits.

For more information on OxySure Systems, visit

Let us hear your thoughts: OxySure Systems Inc. Message Board

OxySure® Systems Inc. (OXYS) is “One to Watch”

August 5, 2013

OxySure® Systems is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.

The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other commercial and municipality facilities in the U.S. Outside the US, OxySure has also already signed significant distribution agreements, including Australia, New Zeeland, the United Kingdom, the Netherlands, Luxembourg, Belgium, Brazil, and South Africa. OxySure’s potential market is at least as large as AEDs and potentially as large as fire extinguishers, which together total at least 500+ million units worldwide.

OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

The company aims to capitalize on market opportunities primarily through partnerships with distributors and OEM customers. Protected by numerous issued patents and patents pending, the company’s products are available over-the-counter without the need for a prescription and has already saved thousands of lives around the globe during various types of medical emergencies.

Let us hear your thoughts: OxySure Systems Inc. Message Board


Select A Month
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Search


    Select A Category
  • 21st Century Holding Company TCHC (1)
  • 5BARz International Inc. BARZ (12)
  • 5G Wireless Communications Inc. FGWC (8)
  • 92 Resources Corp. RGDCF (15)
  • A.P. Pharma Inc. APPA (3)
  • Abazias Inc. ABZA (2)
  • ABcann Global Corp. ABCCF (29)
  • ABV Gold ABVG (11)
  • ACME Sports & Entertainment Inc. ASEN (2)
  • Adaptive Medias Inc. ADTM (6)
  • Advanced ID Corp. AIDO (5)
  • Advanced Medical Isotope Corp. ADMD (10)
  • Advanced Resources Group Ltd. AVRG (3)
  • Advanced Viral Research Corp. ADVR (9)
  • Advanced Visual Systems Inc. AVSC (10)
  • Advanced Voice Recognition Systems Inc. AVOI (11)
  • Advanced Wound Technologies Inc. AWTM (4)
  • Advaxis Inc. ADXS (2)
  • Agora Holdings Inc. AGHI (33)
  • Ahead of the Bulls (1)
  • AISystems, Inc. ASYI (11)
  • Aladdin Trading & Company ADTD (29)
  • Algae Dynamics Corp. ADYNF (31)
  • All American Gold Corp AAGC (13)
  • All Asia Licensing Inc. AASI (1)
  • ALL Fuels & Energy Company AFSE (49)
  • All Grade Mining Inc. HYII (3)
  • All Penny Stocks (3)
  • Allarae Healthcare Inc. ALHI (5)
  • Alliance Creative Group ACGX) (15)
  • Alliance Recovery Corp. ARVY (34)
  • Alltemp, Inc. LTMP (1)
  • APTD (2)
  • Alpine TLI Group Inc. APGR (7)
  • ALR Technologies Inc. ALRT (9)
  • Alternative Construction Technologies Inc. ACCY (10)
  • Alternative Energy Development Corp. ADEC (1)
  • Alternative Fuel Technology Inc. AFTC (1)
  • Alternet Systems Inc. ALYI (47)
  • AM Oil Resources & Technology Inc. AMOR (8)
  • Amarin Corp. AMRN (2)
  • Amaru Inc. AMRU (2)
  • Amerex Group, Inc AEXG (16)
  • American Capital Partners Inc. APRJ (1)
  • American Fiber Green Products Inc. AFBG (1)
  • American Oriental Bioengineering Inc. AOB (3)
  • American Racing Capital Inc. AMRA (2)
  • American Software (2)
  • Amgen Inc. AMGN (2)
  • AmMex Gold Mining Corp. AMXG (2)
  • Ampex Corp AMPX (1)
  • AnalytixInsight Inc. ATIXF (18)
  • Andover Medical Inc. ADOV (2)
  • Angstrom Microsystems Inc. AGMS (46)
  • Apolo Gold and Energy Inc. APLL (1)
  • Apple Inc. AAPL (13)
  • AppSwarm, Inc. SWRM (33)
  • Aquasil International Inc. AQUS (3)
  • Armco Metals Holdings Inc. AMCO (36)
  • AspenBio Pharma APPY (1)
  • Assured Pharmacy Inc. APHY (1)
  • Asta Funding Inc. ASFI (2)
  • Atlantic Energy Solutions Inc. AESO (1)
  • ATSI Communications Inc. ATSX (1)
  • Augme Technologies Inc. AUGT (70)
  • Auric Mining Corp. AUMY (3)
  • Automated Vending Technologies Inc. AVTC (3)
  • Automotive Company GNAU (11)
  • AV1 Group, Inc. AVOP (10)
  • Avalon Oil and Gas Inc. AOGN (16)
  • Avant Diagnostics Inc. AVDX (29)
  • Avatar Systems Inc. AVSY (3)
  • Axiom Management Inc. AXMA (3)
  • Axis Technologies Inc. AXTG (2)
  • B2Digital Inc. BTOD (18)
  • Balatia Airlines BLTA (2)
  • Bald Eagle Energy Inc. BEEI (18)
  • Banjo & Matilda Inc. BANJ (8)
  • (4)
  • Beacon Enterprise Solutions Group BEAC (47)
  • Beacon Equity Research (552)
  • Beijing Med-Pharm Corp. BGJP (2)
  • Bergamo Acquisition Corp. BGMO (15)
  • Big Tree Group Inc. BIGG (36)
  • Bio-Clean International Inc. BCLE (1)
  • Bio-Matrix Scientific Group Inc. BMSN (1)
  • BioCentric Energy Holdings Inc. BEHL (1)
  • Biomagnetics Diagnostics Corp. BMGP (3)
  • bioMETRX Inc. BMRX (1)
  • Bionic Products Corp. BNPD (4)
  • Biophan Technologies Inc. BIPH (1)
  • BioSolar Inc. BSRC (22)
  • Biotech Holdings Ltd. BIOHF (3)
  • Inc. BZRT (9)
  • Black Diamond Brands Corp. BDMHF (1)
  • Blue Diamond Ventures Inc. BLDV (1)
  • Blue Moon Zinc Corp. BMOOF (8)
  • Blue Water Global Group Inc. BLUU (7)
  • Blugrass Energy Inc. BLUG (4)
  • Bollente Companies, Inc. BOLC (7)
  • (1)
  • Boreal Water Collection Inc. BRWC (23)
  • Boston Therapeutics Inc. BTHE (20)
  • Bridgetech Holdings International Inc. BGTH (1)
  • Brighton Oil & Gas Inc. BROG (8)
  • Britannia Mining Inc. BMIN (14)
  • Brite Strike Tactical Illumination Products, Inc. BSTI (41)
  • Brookside Technology Holdings Corp BKSD (2)
  • Bullzi Security Inc. BLLZ (3)
  • BWI Holdings Inc. BWIH (165)
  • Cache Elite Inc. ILUS (10)
  • Cal-Bay International Inc. CBYI (6)
  • Callisto Pharmaceuticals, Inc. (1)
  • Calpian Inc. CLPI (27)
  • CAMAC Energy Inc. CAK (2)
  • Canam Energy Inc. CNGJ (10)
  • CanAm Uranium Corp. CAUI (58)
  • Cannabics Pharmaceuticals Inc. CNBX (14)
  • Capital City Energy Group Inc. CETG (18)
  • Car Monkeys Group CKMY (15)
  • Carbon Sciences Inc. CABN (21)
  • CardioVascular BioTherapeutics Inc. CVBT (5)
  • Cardium Therapeutics Inc. CXM (44)
  • Carl Data Solutions Inc. CDTAF (5)
  • Cascade Technologies Inc. CSDT (2)
  • Cascadia Investment Inc. CDIN (4)
  • Casey Corp. CCPR (1)
  • Cashcow Magazine (4)
  • Cavico Corp. CVIC (3)
  • CD International Enterprises, Inc. CDII (48)
  • CDC Corp. CHINA (4)
  • CelebDirect Inc. CELI (3)
  • Cellceutix Corp. CTIX (18)
  • CellCyte Genetics Corp. CCYG (3)
  • Century Group, Inc. CEYG (1)
  • CEOcast (184)
  • CepTor Corp. CEPO (1)
  • Cereplast Inc. CERP (9)
  • Chancery Resources Inc. CCRY (3)
  • Changing Times Vitamins Inc. SGTB (12)
  • CHDT Corp. CHDO (5)
  • Cherubim Interests Inc. CHIT (36)
  • China 3C Group CHCG (13)
  • China America Holdings Inc. CAAH (8)
  • China Direct Inc. CDS (4)
  • China Education Alliance Inc. CEUA (4)
  • China Energy Recovery Inc. CGYV (12)
  • China Growth Development Inc. CGDI (2)
  • China Health Management Corp CNHC (7)
  • China Health Resource Inc. CHRI (14)
  • China INSOnline Corp. CHIO (1)
  • China Jiangsu Golden Horse Steel Ball Inc. CJGH (3)
  • China Logistics Group Inc. CHLO (11)
  • China Media Group Corp. CHMD (2)
  • China Medicine Corporation CHME (5)
  • China Nuvo Solar Energy Inc. CNUV (3)
  • China Organic Agriculture Inc. CNOA (11)
  • China Petroleum and Chemical Corp. SNP (2)
  • China Voice Holding Corp. CHVC (47)
  • China Wind Systems Inc. CWSI (6)
  • China Wireless Communications Inc. CWLC (4)
  • China Yongxin Pharmaceuticals Inc. CYXN (5)
  • China YouTV Corp. CYTV (1)
  • ChinaTel Group Inc. CHTL (1)
  •, Inc. CIIX (111)
  • Choom Holdings Inc. CHOOF (12)
  • ChromaDex Corp. CDXC (3)
  • City Capital Corp. CTCC (2)
  • Cityside Tickets CIST (21)
  • CleanTech BioFuels Inc. CLTH (10)
  • Cleantech Transit Inc. CLNO (3)
  • Clearly Canadian Beverage Corp. CCBEF (13)
  • Cleartronic Inc. CLRI (52)
  • Clenergen Corp. CRGE (37)
  • CMG Holdings Inc. CMGO (2)
  • Coastal Integrated Services Inc. COLV (13)
  • Coil Tubing Technology Inc. CTBG (1)
  • Colorado Goldfields Inc. CGFI (5)
  • Colt Resources Inc. COLTF (13)
  • Columbia River Resources Inc. CRVR (1)
  • CoMedia Corp. CMTN (1)
  • CommercePlanet Inc. CPNE (4)
  • Compress Technologies Inc. CTLG (17)
  • Conforce International Inc. CFRI (2)
  • CAJT (9)
  • Cono Italiano Inc. CNOZ (12)
  • Consorteum Holdings, Inc. CSRH (171)
  • Consorteum Holdings, Inc. CSRH (4)
  • ContentChecked Holdings Inc. CNCK (60)
  • Continental Fuels Inc. CFUL (2)
  • Converde Energy USA Inc. XFUL (12)
  • Convergence Technology Group Inc. CNVC (7)
  • Copper King Mining Corp. CPRK (2)
  • Cord Blood America Inc. CBAI (102)
  • Crdentia Corp CRDT (12)
  • Creative Vistas Inc. CVAS (2)
  • Crystal International Travel Group Inc. CINT (4)
  • Cubic Energy Inc. QBC (2)
  • Cybermesh International Corp. CYTL (1)
  • Cyclone Power Technologies Inc. CYPW (9)
  • CYIOS Corp. CYIO (1)
  • Daily Views (13)
  • Dakshidin Corp. DKSC (5)
  • Data Call Technologies Inc. DCLT (25)
  • Daulton Capital Corp. DUCP (26)
  • Davi Skin Inc. DAVN (1)
  • Debt Resolve Inc. DRV (2)
  • Debut Broadcasting Corporation Inc. DBTB (1)
  • Deep Blue Marine Inc. DPBM (6)
  • Deep Down Inc. DPDW (15)
  • Deer Valley Corp. DVLY (2)
  • Defense Solutions Inc. DFSH (3)
  • Delta Mining and Exploration Corp. DMXC (1)
  • Dermisonics Inc. DMSI (1)
  • Destination Television Inc. DSTV (17)
  • Dhanoa Minerals Ltd. DHNA (4)
  • DigitalPost Interactive Inc. DGLP (8)
  • Document Capture Technologies Inc. DCMT (3)
  • DoMark International Inc. DOMK (29)
  • Dominovas Energy Corp. DNRG (73)
  • Dragon Capital Group Corp. DRGV (11)
  • Dragon International Group Corp. DRGG (2)
  • Duma Energy Corp. DUMA (20)
  • Duska Therapeutics Inc. DSKA (1)
  • Dutton Associates (88)
  • DXP Enterprises Inc. DXPE (4)
  • Dynamic Media Holdings Inc. DYMH (6)
  • Dynamic Response Group Inc. DRGP (6)
  • Dynasty Limousine Inc. DNYS (19)
  • Earth Dragon Resources Inc. EARH (10)
  • Eastbridge Investment Group Corp. EBIG (1)
  • Ebenefits Direct, Inc. EBFD (21)
  • eCareer Holdings Inc. ECHI (9)
  • Echo Therapeutics Inc. ECTE (5)
  • EcoloCap Solutions Inc. ECOS (2)
  • Ecologic Transportation Inc. EGCT (11)
  • Ecosciences Inc. ECEZ (1)
  • Ecotality, Inc. ECTY (67)
  • eCrypt Technologies Inc. ECRY (79)
  • EdgeTech International Inc. EGIL (6)
  • eDoorways Corp. EDWY (183)
  • Inc. EFSF (4)
  • EFuel EFN Corp. EFUL (1)
  • EGPI Firecreek Inc. EFIR (1)
  • Elephant Talk Communications Corp. ETAK (8)
  • Elephant Talk Communications Inc. ETAK (2)
  • Elleipsis Global Travel Solutions Inc. EGTS (3)
  • Elray Resources Inc. ELRA (11)
  • Elron Electronic Industries Ltd. ELRN (1)
  • Emerging Media Holdings Inc. EMDH (22)
  • Empire Energy Corporation International EEGC (3)
  • Endeavor Explorations Inc. EAVR (7)
  • Endeavour Silver Corp. EXK (3)
  • Endevco Inc. EDVC (2)
  • Energtek Inc. EGTK (61)
  • Enherent Corp. ENHT (2)
  • EnterConnect Inc. ECNI (5)
  • Enterprise Oilfield Group Inc. E.TO (13)
  • EnXnet Inc. EXNT (1)
  • Epazz, Inc. EPAZ (48)
  • Equity Stock Analysis (1)
  • ER Urgent Care Holdings Inc. ERUC (6)
  • ERF Wireless Inc. ERFB (15)
  • Essential Innovations Technology Corp. ESIV (2)
  • Inc. ETLC (3)
  • Ethema Health Corporation GRST (7)
  • Euoko Group Inc. EUOK (2)
  • EV Innovations Inc. EVII (189)
  • EV Transportation Inc. EVTP (7)
  • EVIO, Inc. EVIO (33)
  • Exchange Media Corp. EXMD (9)
  • Exeter Resource Corp. XRA (2)
  • eXp World Holdings, Inc. EXPI (81)
  • Expert Group Inc. EXPT (5)
  • ExpressIR Inc. (1)
  • Extreme Motorsports of California, Inc. EMOC (26)
  • ezBanc-A Stocklender's Journal (6)
  • Falcon Crest Energy FCEN (75)
  • Falcon Ridge Development Inc. FCNR (2)
  • Famous Uncle Als Hot Dogs & Grille Inc FDOG (10)
  • FANDOM SPORTS Media Corp. FDMSF (5)
  • Fastfunds Financial Corp. FFFC (17)
  • Financial Media Group, Inc. FNGP (26)
  • Financial Services Exchange FSE (1)
  • First Cobalt Corp. FTSSF (49)
  • First Titan Corp. FTTN (45)
  • FlexWeek Inc. FXWK (11)
  • FluoroPharma Medical Inc. FPMI (46)
  • Foldera, Inc. FDRA (11)
  • Force Energy Corp. FORC (5)
  • FormCap Corp. FRMC (29)
  • Fortune Market Media Inc. FTMM (5)
  • Franklin Mining Inc. FMNJ (1)
  • Freedom Leaf Inc. FRLF (12)
  • Fresh Harvest Products Inc. FRHV (7)
  • Fresh Promise Foods Inc. FPFI (12)
  • Freshstart Properties Inc. FSPP (1)
  • FrogAds Inc. FROG (6)
  • Frozen Food Gift Group Inc. FROZ (5)
  •, Inc. FNDM (56)
  • Fushi Copperweld Inc. FSIN (2)
  • GainClients Inc. GCLT (9)
  • Galenfeha Inc. GLFH (28)
  • Gastar Exploration Ltd. GST (2)
  • Gemini Explorations Inc. GXPI (12)
  • Gen2media Corp. GTWO (2)
  • General Environmental Management Inc. GEVI (56)
  • General Metals Inc. GNMT (1)
  • General Steel Holdings Inc. GSI (3)
  • GeoBio Energy Inc. GBOE (1)
  • GeoEye Inc. GEOY (4)
  • GeoPharma Inc GORX (1)
  • Giggles N’ Hugs Inc. GIGL (90)
  • Global Alumina Corp. GLA.U (1)
  • Global General Technologies Inc. GLGT (1)
  • Global Hemp Group, Inc. GBHPF (10)
  • Global Payout Inc. GOHE (109)
  • Global Realty Development Corp. GRLY (10)
  • Global Resource Corporation GBRC (48)
  • Global Roaming Distribution Inc. GRDB (34)
  • GlobalWise Investments Inc. GWIV (129)
  • GNCC Capital Inc. GNCP (24)
  • Golden West Brewing Company Inc. GWBC (3)
  • GoldSpring Inc. GSPG (4)
  • Google, Inc. GOOG (8)
  • (1)
  • Grandview Gold Inc. GVGDF (2)
  • Gray Publishing & Media, Inc. GPMIJ (15)
  • Graystone Park Enterprises Inc. GPKE (7)
  • Great Plains Holdings Inc. GTPH (28)
  • Green Earth Technologies GETG (1)
  • Green Star Alternative Energy Inc. GSAE (2)
  • Green Star Products Inc. GSPI (2)
  • Green Technology Solutions Inc. (GTSO) (19)
  • Greenbelt Resources Corp. GRCO (1)
  • Greenchek Technology Inc. GCHK (18)
  • Greenkraft, Inc. GKIT (22)
  • Greenstone Holdings Inc. GSHN (2)
  • Grey Cloak Tech, Inc. GRCK (24)
  • GRILLiT Inc. GRLT (8)
  • Growblox Sciences Inc. GBLX (24)
  • GT Legend Automotive Holdings Inc. GTLA (2)
  • GTX Corp GTXO (49)
  • Gulf Western Petroleum Corp. GWPC (3)
  • GWS Technologies Inc. GWSC (4)
  • Halcyon Jets Holdings Inc. HJHO (15)
  • Halitron Inc. HAON (11)
  • Hanover Financial Services (17)
  • Harbin Electric Inc. HRBN (2)
  • Harvey Electronics Inc. HRVE (1)
  • Hasco Medical Inc. HASC (7)
  • Hathway Corp. HWYI (1)
  • HeadsUp Entertainment International Inc. HDUP (3)
  • Healthnostics Inc. HNSO (1)
  • HealthSonix Inc. HSXI (1)
  • HealthSport Inc. HSPO (14)
  • Heartland Inc. HTLG (1)
  • Heartland Oil and Gas Corp. HTOG (7)
  • Hemis Corporation HMSO (19)
  • Hemisphere Gold Inc. HPGI (1)
  • Hemp Inc. HEMP (25)
  • Hendrx Corp. HDRX (1)
  • Hi-Shear Technology Corp. HSR (3)
  • HighCom Global Security Inc. HCGS (19)
  • HII Technologies Inc. HIIT (8)
  • Holloman Energy Corp. HENC (2)
  • Holmes Osborne (6)
  • Hologic Inc. HOLX (4)
  • Home Shopping Latino Inc. HSPG (8)
  • Hong Kong Highpower Technology Inc. HPJ (2)
  • HotOTC (61)
  • HotStockChat (3)
  • HotStockMarket (HSM) (3)
  • HST Global Inc. HSTC (11)
  • Hunt Gold Corp. HGLC (32)
  • HWI Global Inc. HWIC (3)
  • Hydrogen Corp. HYDG (1)
  • i-Level Media Group Inc. ILVL (3)
  • i2 Telecom International Inc. ITUI (7)
  • iB3 Networks Inc. IBNW (1)
  • IceWEB Inc. IWEB (5)
  • ICP Solar Technologies Inc. ICPR (3)
  • IDGLOBAL Corp. IDGJ (2)
  • IDO Security Inc. IDOI (22)
  • IEG Holdings Corp. IEGH (22)
  • IFAN Financial Inc. IFAN (34)
  • iGambit, Inc. IGMB (5)
  • Imaging3 Inc. IMGG (2)
  • ImaRx Therapeutics Inc. IMRX (2)
  • Immune Therapeutics Inc. IMUN (11)
  • Impact E-Solutions Corp. IESO (1)
  • Imperial Petroleum Inc. IPMN (10)
  • Inca Designs Inc. IDGI.PK (4)
  • Independent Film Development Corp. IFLM (1)
  • Index Oil and Gas Inc. IXOG.OB (5)
  • India Globalization Capital, Inc. IGC (21)
  • Industrial Biotechnology Corp. IBOT (1)
  • Infinite Group Inc. IMCI (48)
  • Inform Worldwide Holdings, Inc. IWWI (27)
  • InMed Pharmaceuticals, Inc. IMLFF (38)
  • Intec LTD ICLJY (1)
  • IntegraMed America Inc INMD (1)
  • Intelecom Inc. IECM (3)
  • Intelimax Media Inc. IXMD (31)
  • Intelligent Highway Solutions Inc. IHSI (6)
  • Intercept Energy Services Inc. IESCF (7)
  • Interleukin Genetics Inc. ILI (1)
  • International Barrier Technology Inc IBTGF (1)
  • International Consolidated Companies Inc. INCC (2)
  • International Stem Cell Corp. ISCO (226)
  • Inventergy Global Inc. INVT (15)
  • Investor Village (9)
  • Investors Business Daily (4)
  • InvestorsProfs (1)
  • InvestSource (11)
  • IPOs (8)
  • IR Biosciences Holdings Inc IRBS (3)
  • Isonics Corp. ISON (1)
  • ItsAboutFinance (2)
  • JC Data Solutions Inc. JCDS (4)
  • Joytoto USA Inc. JYTO (14)
  • JZZ Technologies Inc. JZZI (3)
  • KAL Energy Inc. KALG (3)
  • Kallo Inc. KALO (43)
  • Kandi Technologies Corp. KNDI (3)
  • KCM Holding Corp. KCMH (3)
  • Kingslake Energy Inc. KGLJ (2)
  • Klondex Mines Ltd. KLNDF (1)
  • Knobias KNBS (5)
  • Kootenay Zinc Corp. KTNNF (12)
  • Kraig Biocraft Laboratories Inc. KBLB (88)
  • L&L International Holdings Inc. LLFH (2)
  • Laguna Blends Inc. LAGBF (53)
  • Lantis Laser Inc. LLSR (5)
  • Last Mile Logistics Group LMLG (4)
  • Latitude 360 Inc. LATX (21)
  • LD Holdings Inc. LDHL (14)
  • Legacy Holdings Inc. LGYH (1)
  • Legacy Ventures International Inc. LGYV (24)
  • Legend Media Inc. LEGE (4)
  • Lexaria Bioscience Corp. LXRP (74)
  • Liberty Leaf Holdings Ltd. LIBFF (10)
  • Lifespan Inc. LSPN (1)
  • Lime Energy Corp. LIME (3)
  • Lingo Media Corp. LMDCF (18)
  • Linkwell Corporation LWLL (4)
  • Liquor Group Wholesale Inc. LIQR (22)
  • Inc. LFLS (47)
  • LOGIC Devices Inc. LOGC (1)
  • Logility Inc. LGTY (1)
  • LoJack Corp LOJN (3)
  • Longhai Steel Inc. LGHS (10)
  • LottoGopher Holdings Inc. LTTGF (26)
  • Lotus Pharmaceuticals Inc. LTUS (1)
  • Low Carbon Technologies (LWCTF) (3)
  • Lucas Energy, Inc. LEI (17)
  • Mabwe Minerals Inc. MBMI (56)
  • Macquarie Infrastructure Company MIC (5)
  • Maine and Maritime Corp. MMA (1)
  • Majic Wheels Corp. MJWL (6)
  • Makeup Inc. MAKU (2)
  • Mammoth Energy Group Inc. MMTE (5)
  • Mantra Venture Group Ltd. MVTG (10)
  • Marijuana Company of America, Inc. MCOA (37)
  • Mariner’s Choice International Inc. MCII (2)
  • Martin Nutraceuticals MNIU (11)
  • Material Technologies Inc. MTCH (44)
  • Max Media Group Inc. MXMI (9)
  • Max Sound Corp. MAXD (30)
  • MC Endeavors Inc. MSMY (2)
  • MedeFile International Inc. MDFI (46)
  • MediaG3 Inc. MDGC (1)
  • Medical Cannabis Payment Solutions (REFG) (13)
  • Medical Cannabis Payment Solutions REFG (19)
  • Medical Innovation Holdings, Inc. MIHI (16)
  • Medical Transcription Billing Corp. MTBC (13)
  • Medina International Holdings Inc. MIHI (3)
  • Medisafe 1 Technologies Corp. MFTH (3)
  • Medivisor Inc. MVSR (1)
  • Mega Media Group, Inc. MMDA (30)
  • MegaWest Energy Corporation MGWSF (2)
  • Memry Corp. MRY (2)
  • Metro One Development Inc. MODI (2)
  • Mexico Energy Corp. MXC (1)
  • MGX Minerals, Inc. MGXMF (52)
  • Micro Identification Technologies Inc. MMTC (44)
  • MicrocapMoney (2)
  • Microsoft Corporation MSFT (4)
  • Midway Gold Corp. MDW (1)
  • Military Resale Group MYRL (19)
  • Minco Silver Corp. MSV.TO (1)
  • Mindpix Corp. MNDP (1)
  • MIP Solutions Inc. MSOL (7)
  • MIT Holding MITD (36)
  • MitoPharm Corp. MTPH (1)
  • Mizati Luxury Alloy Wheels, Inc. MZTI (14)
  • Mobile Entertainment Inc. MBEI (1)
  • Mobile Lads Corp. MOBO (43)
  • Momentous Entertainment Group Inc. MMEG (19)
  • Monaker Group Inc. MKGI (48)
  • Money4Gold Holdings Inc. MFGD (3)
  • Holdings Inc. MBKR (2)
  • Mosquito Consolidated Gold Mines Limited MSQ.V (1)
  • Moxian Inc. MOXC (62)
  • mPhase Technologies Inc. XDSL (12)
  • MSE Enviro-Tech Corp. MEVT (4)
  • Muscle Flex Inc. MFLI (55)
  • MusclePharm Corp. MSLP (23)
  • Mvive Inc. MVIV (22)
  • My Automated Advisor (4)
  • MyECheck Inc. MYEC (99)
  • Inc. MYST (1)
  • Nanogen Inc. NGEN (2)
  • Nanometrics Inc. NANO (1)
  • NanoSensors Inc. NNSR (1)
  • NanoTech Entertainment Inc. NTEK (30)
  • Napster, Inc. NAPS (5)
  • National Automation Services Inc. NASV (67)
  • National Coal Corp. NCOC (2)
  • National Waste Management Holdings Inc. NWMH (24)
  • Naturally Iowa Inc. NLIA (2)
  • NavStar Technologies Inc. NVSR (16)
  • nCoat Inc NCOA (8)
  • Neah Power Systems NPWZ (14)
  • Neohydro Technologies Corp. NHYT (4)
  • Neoprobe Corp. NEOP (6)
  • NeoStem Inc. NBS (6)
  • Net Element Inc. NETE (19)
  • NetSol Technologies Inc NTWK (64)
  • Neurobiological Technologies Inc. NTII (3)
  • NeuroMama Ltd. NERO (15)
  • Neutra Corp. NTRR (37)
  • New Asia Gold Corp. NWAG (1)
  • New Generation Biofuel Holdings Inc. GNB (3)
  • NewMarket China Inc. NMCH (7)
  • NewMarket Technology Inc. NMKT (7)
  • Newport Digital Technologies Inc. NPDT (61)
  • Nexia Holdings Inc. NXHD (51)
  • NexMed Inc. NEXM (8)
  • NeXplore Corp. NXPC (4)
  • Next One Interactive Inc. NXOI (7)
  • NextGen Bioscience Inc. NXGB (1)
  • NextPhase Wireless Inc. NPHS (1)
  • Nexus Enterprise Solutions Inc. NXES (30)
  • NF Energy Saving Corp. of America NFES (1)
  • Nhale Inc. NHLE (18)
  • Nilam Resources Inc. NILR (4)
  • Nitro Petroleum Inc. NTRO (5)
  • North Bay Resources Inc. NBRI (10)
  • NuTech Inc. NTCI (1)
  • Nutra Pharma Corp. NPHC (21)
  • NutraNomics Inc. NNRX (30)
  • NuVim Inc. NUVM (1)
  • NVIDIA Corp. NVDA (1)
  • NXGen Holdings Inc. NXGH (1)
  • Oakridge Global Energy Solutions Inc. OGES (63)
  • Obee's Franchise Systems Inc. OBFM (1)
  • OBJ Enterprises Inc. OBJE (27)
  • Odyne Corporation ODYC (15)
  • Omega Commercial Finance Corp. OCFN (2)
  • OmniaLuo Inc. OLUO (1)
  • Omnicity Corp. OMCY (26)
  • Omninet Media.Com, Inc. ONMC (5)
  • On The Go Healthcare Inc. MODI (13)
  • On the Move Systems Inc. OMVS (102)
  • Oncolin Therapeutics Inc. OCOL (1)
  • One Step Vending Corp. KOSK (2)
  • One World Holdings Inc. OWOO (61)
  • Ones to Watch (1,353)
  • Onstream Media Corp. ONSM (5)
  • Onteco Corp. ONTC (4)
  • Open Energy Corp. OEGY (4)
  • Optical Systems Inc. OPSY (2)
  • Oramed Pharmaceuticals Inc. ORMP (2)
  • Organic Alliance Inc. ORGC (2)
  • ORHub, Inc. ORHB (32)
  • (82)
  • OtcStockExchange (5)
  • OurPet's Company OPCO (78)
  • OxySure Systems Inc. OXYS (23)
  • P2 Solar Inc. PTOS (24)
  • Pacific Gold Corp. PCFG (3)
  • Pamplona Picks (1)
  • Pan Global Corp. PGLO (82)
  • PanGenex Corp. PGCX (3)
  • Paramount Gold and Silver Corp. PZG (3)
  • Patient Access Solutions Inc. PASO (7)
  • Patriot Energy Corp. dba TelTeck Solutions Inc PGYC.PK (11)
  • Patriot One Technologies, Inc. PTOTF (25)
  • Patriot Scientific Corp. PTSC (6)
  • Peace Arch Entertainment Group Inc. PAE (1)
  • Peoples Educational Holdings Inc. PEDH (2)
  • Perf Go Green Holdings Inc. PGOG (12)
  • Perfect Web Technologies, Inc PWBI (11)
  • Perfectenergy International Ltd. PFGY (1)
  • Performance Health Technologies Inc. PFMH (31)
  • Pet DRX Corp. VETS (1)
  • Petro Resources Corp. PRC (2)
  • Petrogress, Inc. PGAS (27)
  • PetroSun Inc. PSUD (41)
  • Petroteq Energy Inc. PQEFF (50)
  • Phantom Fiber Corp. PHFB (2)
  • Pilot Financial Communications (3)
  • Pipex Pharmaceuticals Inc. PP (2)
  • PITOOEY! Inc. PTOO (14)
  • Pivot Pharmaceuticals Inc. PVOTF (1)
  • Planet Nutrition Inc. PNHL (4)
  • Platina Energy Group Inc. PLTG (8)
  • PlayBOX Inc. PYBX (5)
  • Players Network PNTV (15)
  • Pluristem Therapeutics Inc. PSTI (10)
  • Positron Corp. POSC (3)
  • PotNetwork Holding, Inc. POTN (59)
  • Power of the Dream Ventures (1)
  • Power Play Development Corp. PWPY (17)
  • Powersafe Technology Corp. PWSF (1)
  • Premier Energy Corp. PNRC (1)
  • Pressure BioSciences Inc. PBIO (41)
  • PreveCeutical Medical Inc. PRVCF (22)
  • PRG Group Inc. PRGJ (2)
  • PrimEdge Inc. PEDI (1)
  • Private Equity Securities (93)
  • Pro Motors Group Corp. PMGU (2)
  • Pro Travel Network Inc. PTVL (2)
  • ProBility Media Corp. PBYA (33)
  • ProGaming Platforms Corp. PPTF (22)
  • Proginet Corp. PRGF (3)
  • Prom Resources PRMO (9)
  • Propalms Inc. PRPM (3)
  • Provectus Pharmaceuticals Inc. PVCT (12)
  • Puget Technologies Inc. PUGE (23)
  • Pulmo BioTech Inc. PLMO (4)
  • Puramed Bioscience Inc. PMBS (3)
  • Pure Biofuels Corp. PBOF (4)
  • Pure H2O Inc. PURH (1)
  • Pure Hospitality Solutions Inc. PNOW (99)
  • Purio Inc. PURO (5)
  • Puritan Financial Group Inc. PTNG (1)
  • Purple Beverage Company Inc. PPBV (8)
  • QED Connect Inc. QEDC (4)
  • Qiao Xing Universal Telephone Inc. XING (2)
  • QPC Lasers Inc. QPCI (3)
  • Qualcomm Inc. QCOM (2)
  • QualityStocks for Women (16)
  • QualityStocks Partner StockGuru (3,878)
  • QualityStocks Stock Newsletter (551)
  • QualityStocks Stock Newsletters (18,172)
  • QualityStocks Video Charts (286)
  • Market Basics (6)
  • QualityStocksNewsBreaks (839)
  • Quantum Fuel Systems Technologies Worldwide Inc. QTWW (15)
  • Quantum International Corp. QUAN (3)
  • Quasar Aerospace Industries Inc. QASP (6)
  • QuoteMedia Inc. QMCI (120)
  • Rafarma Pharmaceuticals Inc. RAFA (31)
  • Rainbow Coral Corp. RBCC (33)
  • Rancher Energy Corp. RNCH (9)
  • Raptor Resources Holdings Inc. RRHI (50)
  • Raven Gold Corp. RVNG (3)
  • Red Lake Exploration Inc. RLKX (19)
  • RegalWorks Media Inc. RWMI (4)
  • Regenicin, Inc. RGIN (6)
  • Reign Sapphire Corp. RGNP (13)
  • Reliant Financial Services Inc. RFNS (1)
  • Renhuang Pharmaceuticals Inc. RHGP (3)
  • ReoStar Energy Corp. REOS (1)
  • Resort Savers Inc. (RSSV) (10)
  • Revett Minerals (1)
  • RJD Green Inc. RJDG (19)
  • Rock Energy Resources Inc. RCKE (4)
  • Rodman & Renshaw (432)
  • Ronn Motor Company Inc. RNNM (6)
  • Rox Resources Ltd. RXRS (3)
  • Royal Quantum Group, Inc. RYQG (10)
  • Royal Standard Minerals Inc. RYSMF (2)
  • Rudy Nutrition RUNU (27)
  • RXi Pharmaceuticals Corp. RXII (3)
  • Santa Fe Gold Corp. SFEG (5)
  • Santa Fe Holding Company SFHD (3)
  • Save The World Air Inc. ZERO (12)
  • Savoy Energy Corp. SNVP (26)
  • SavWatt USA, Inc. SAVW (5)
  • Seabridge Gold Inc. SA (1)
  • Seawright Holdings Inc. SWRI (1)
  • Sector 10 Inc. SECI (78)
  • SES Solar Inc. SESI (2)
  • Seven Arts Pictures plc SAPX (1)
  • Seven Arts Pictures PLC SAPXF (5)
  • Shazam Stocks (22)
  • ShotPak Inc. SHTP (35)
  • Shumate Industries SHMTE (1)
  • Sibling Group Holdings Inc. SIBE (55)
  • Sierra Gold Corp. SGCP (2)
  • Signature Devices Inc. SDVI (9)
  • Silver Dragon Resources Inc. SDRG (1)
  • Silver Falcon Mining Inc. SFMI (1)
  • SilverSun Technologies Inc. SSNT (30)
  • Simtrol Inc. SMRL (74)
  • Simulated Environment Concepts Inc. SMEV (130)
  • Singlepoint Inc. SING (150)
  • Sino Agro Food Inc. SIAF (1)
  • Sinobiomed Inc. SOBM (4)
  • Sinovac Biotech Ltd SVC (1)
  • Sipp Industries Inc. SIPC (2)
  • Sixty Six Oilfield Services Inc. SSOF (1)
  • Skinny Nutritional Corp. SKNY (19)
  • Skinvisible, Inc. SKVI (41)
  • Sky Petroleum Inc. SKPI (1)
  • SkyPostal Networks Inc. SKPN (66)
  • Small Cap Sentinel (2)
  • Small Cap Sleeper (3)
  • Smallcap Bullets (2)
  • (22)
  • SmallCapVoice (428)
  • Smoky Market Foods Inc. SMKY (9)
  • SocialPicks (1)
  • Sofame Technologies Inc SDW.V (1)
  • Sohm Inc. SHMN (14)
  • Solanex Management Inc. SLNX (15)
  • Solar Energy Initiatives Inc. SNRY (14)
  • Solar Wind Energy Tower Inc. SWET (15)
  • Solarfun Power Holdings Co. Ltd. SOLF (2)
  • Soul and Vibe Interactive Inc. SOUL (14)
  • South Sea Energy Corp. SSGY (7)
  • Soyo Group Inc SOYO (2)
  • SpaceDev Inc. SPDV (5)
  • Sparta Commercial Services Inc. SRCO (31)
  • Speedemissions Inc. SPMI (14)
  • Spicy Pickle Inc SPKL (18)
  • SpongeTech Delivery Systems Inc. SPNG (14)
  • Sports Pouch Beverage Company Inc. SPBV (1)
  • Star Mountain Resources Inc. SMRS (37)
  • Start Scientific Inc. STSC (22)
  • Stealth Technologies, Inc. STTH (3)
  • Stock Market E-News (1)
  • Stock Promoters (4)
  • StockEgg (14)
  • Stocks to Watch (1,951)
  • StocksJournal (2)
  • StockUPTicks (165)
  • Stockwire (6)
  • Strategic American Oil Corp SGCA (32)
  • Stratos Renewables Corp. SRNW (89)
  • StreamTrack Inc. STTK (31)
  • Striker Oil & Gas Inc. SOIS (4)
  • Sun Motor International Inc. SNMO (1)
  • SUN Sports & Entertainment Inc. SSPE (3)
  • Sunshine Biopharma Inc. SBFM (6)
  • Superlattice Power Inc. SLAT (60)
  • SupportSave Solutions, Inc. SSVE (10)
  • Surefect Holdings Inc. SUFH (1)
  • Suspect Detection Systems Inc. SDSS (37)
  • Sweet Success Enterprises Inc. SWTS (35)
  • Swiss Hawk AG SWHKF (1)
  • Symposium Production Corp. SYPJ (1)
  • Tactical Air Defense Services, Inc. TADF (15)
  • Tao Minerals Ltd. TAOL (1)
  • TapImmune, Inc. TPIV (15)
  • Tapinator, Inc. TAPM (26)
  • Taplmmune Inc. TPIM (1)
  • Technology Applications International Inc. NUUU (25)
  • TechPrecision Corp. TPCS (4)
  • Tecton Corp. TTNC (3)
  • Teewinot Life Sciences (9)
  • Teknik Digital Arts Inc. TKNK (10)
  • Telanetix Inc. TNXI (2)
  • Teletouch Communications Inc. TLLE (5)
  • Terax Energy Inc. TEXG (32)
  • Terme Bancorp TMEB (1)
  • Terra Nostra Resources Corp. TNRO (25)
  • The Amergence Group AMNG (8)
  • The Aristocrat Group Corp. ASCC (113)
  • The Bowser Report (68)
  • The Bull Report (32)
  • The Capital Report (5)
  • The DIRECTV Group Inc. DTV (1)
  • The Fight Zone Inc. TFZI (12)
  • The Green Organic Dutchman Holdings Ltd. TGOD (11)
  • The Guitammer Company Inc. GTMM (38)
  • The International Traders Expo (30)
  • The Mobile Star Corp. MBST (7)
  • The Motley Fool (3)
  • The Mundus Group Inc. MNDS (1)
  • The Penny Stock Blog (28)
  • The Principal Structure Fund, Inc. PSF (2)
  • The Tracking Corp. TRKG (1)
  • The UpTurn, Inc. UPTR (20)
  • The Wall Street Savant (24)
  • The Wide Angle (3)
  • Thresher Industries Inc. THRR (15)
  • Tidelands Oil and Gas Corp. TIDE (1)
  • Tiens Biotech Group USA Inc. TBV (1)
  • TMT Capital Corp. TMTP (1)
  • TNI BioTech Inc. TNIB (16)
  • Tombstone Exploration Corp. TMBXF (9)
  • TOMI Environmental Solutions Inc. TOMZ (4)
  • Tootie Pie Company, Inc. TOOT (11)
  • Torchlight Energy Resources, Inc. TRCH (2)
  • TradeShow Marketing Company Inc. TSHO (21)
  • TransWorldNews (4)
  • Tri-Star Holdings Inc. TSHL (31)
  • Trimax Corp. TMXN (31)
  • TripleCrownStocks (9)
  • True 2 Beauty Inc. TRTB (43)
  • TwinTrader (8)
  • TXP Corporation TXPO (1)
  • TZ Ltd. TZL.AX (1)
  • U.S. Mine Makers Inc. USMM (1)
  • uKarma Corporation UKMA (1)
  • Ultitek Ltd. UITK (21)
  • Unbridled Energy Corporation TSX-UNE (21)
  • Unico Inc. UNCO (3)
  • Universal Bioenergy Inc. UBRG (3)
  • Universal Detection Technology UNDT (41)
  • Universal Energy Corp. UVSE (19)
  • Universal Property Development and Acquisition UPDA (4)
  • Universal Tracking Solutions Inc. UTRK (13)
  • Universal Travel Group UTVG (14)
  • UpSNAP Inc. UPSN (1)
  • Uranium Energy Corp. UEC (64)
  • Uranium Hunter Corp. URHN (17)
  • Urex Energy Corp. URXE (1)
  • USA Recycling Industries Inc. USRI (21)
  • USA Superior Energy Inc. USSU (9)
  • Ustelematics Inc. UTLM (27)
  • Utah Uranium Corp. UTUC (2)
  • Utilicraft Aerospace Industries Inc. UITA (2)
  • ValueRich & iValueRich (9)
  • Vaporin Inc. VAPOD (2)
  • VentriPoint Diagnostics Ltd. VPTDF (26)
  • Veritas Pharma Inc. VRTHF (17)
  • Vermillion Inc. VRML (3)
  • Vertical Branding Inc. VBDG (11)
  • VIASPACE, Inc. VSPC (185)
  • Victory Energy Corp. VYEY (29)
  • Victory Square Technologies Inc. VSQTF (2)
  • Vidshadow Inc. VSHD (1)
  • View Systems Inc. VSYM (16)
  • Viper Networks Inc. VPER (2)
  • Viral Genetics Inc. VRAL (3)
  • Viropro International Inc. VPRO (2)
  • VirTra Systems Inc. VTSI (22)
  • Viscount Systems Inc. VSYS (27)
  • visionGATEWAY Inc. VGWA (1)
  • VistaGen Therapeutics Inc. VSTA (104)
  • Visualant Inc. VSUL (5)
  • Vital Products Inc. VTLP (5)
  • Viyya Technologies Inc. VYON (2)
  • VizStar Inc VIZS (24)
  • Voiceserve Inc. VSRV (18)
  • Vortex Resources Corp. VTEX (7)
  • Vsurance Inc. VSUR (3)
  • Vyteris Inc. VYHN (1)
  • W2 Energy Inc. WWEN (13)
  • Wall Street News Alert (76)
  • WallStreetGrapevine (12)
  • WaterPure International Inc. WPUR (4)
  • Wave Systems Corp. WAVX (5)
  • Week in Review (2)
  • Well Power Inc. WPWR (77)
  • Wescorp Energy Inc. WSCE (18)
  • West Canyon Energy Corp. WCYO (1)
  • Western Standard Energy Corp. WSEG (7)
  • Who's Your Daddy Inc. WYDI (7)
  • WikiLoan Inc. WKLI (14)
  • Wind Energy America Inc. WNEA (3)
  • Wisdom Homes of America Inc. WOFA (15)
  • Wits Basin Precious Minerals Inc. WITM (2)
  • Woize International Ltd. WOIZ (1)
  • WordLogic Corp. WLGC (40)
  • Workstream Inc. WSTM (9)
  • WorldWater & Solar Technologies Corp. WWAT (10)
  • Worldwide Energy and Manufacturing WEMU (12)
  • Worldwide Manufacturing USA Inc. WWMU (6)
  • WRIT Media Group Inc. WRIT (36)
  • X-Change Corp. (XCHC) (2)
  • Xaar Plc XAARF (1)
  • Xenomics Inc. XNOM (1)
  • XsunX Inc. XSNX (17)
  • XZERES Corp. XPWR (2)
  • Younger America YNGR (13)
  • Zacks Investment Research (11)
  • ZAGG Inc. ZAGG (9)
  • Zaldiva Inc. ZLDV (3)
  • ZAP ZAAP (15)
  • ZBB Energy Corp ZBB (7)
  • Zenosense Inc. ZENO (53)
  • Zentric Inc. ZNTR (14)
  • Zevotek Inc. ZVTK (8)
  • Zinc One Resources Inc. ZZZOF (7)
  • Znomics Inc. ZNOM (3)
  • Newsletter Signup

    Stay ahead of the pack with QualityStocks and receive "The QualityStocks Daily", our summary formatted newsletter containing stock tips from hundreds of online investment newsletters.

    Rotate your device 90° to view site.